Trials / Conditions / Zika Virus Infection

Zika Virus Infection

22 registered clinical trials studyying Zika Virus Infection — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910	Institut Pasteur du Cambodge	—
Completed	Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine C NCT06334393	Valneva Austria GmbH	Phase 1
Unknown	Evaluation of Viral Replication by Tonate Virus (TONV) and Zika Virus (ZIKV), Within an ex Vivo Trophoblast an NCT05589012	Assistance Publique - Hôpitaux de Paris	—
Completed	Adherence to Care for Children With Congenital Zika Virus Infection in Puerto Rico NCT05041439	Massachusetts General Hospital	N/A
Completed	Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001) NCT04033068	Themis Bioscience GmbH	Phase 1
Completed	Zika and Neurodevelopment Among Infants in Grenada NCT04697147	Windward Islands Research and Education Foundation	N/A
Completed	Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG) NCT03624946	Emergent BioSolutions	Phase 1
Withdrawn	ZIKAlliance Natural History Study NCT03204409	University of Heidelberg Medical Center	—
Completed	Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA NCT03776903	InBios International, Inc.	—
Completed	Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika V NCT03425149	Valneva Austria GmbH	Phase 1
Terminated	Applying Wolbachia to Eliminate Dengue NCT03055585	Gadjah Mada University	N/A
Completed	Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia NCT03631719	Universidad de Antioquia	—
Completed	Safety and Immunogenicity of BBV121 NCT04478656	Bharat Biotech International Limited	Phase 1
Completed	Efficacy of Aquatic Physiotherapy in Children With Microcephaly by Zika Virus Congenital Syndrome NCT03330600	Universidade Federal de Pernambuco	N/A
Completed	VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents NCT03110770	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immuno NCT03008122	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Terminated	Estimated Cumulative Incidence of Zika Infection at the End of the First Epidemic in the French West Indies in NCT03161444	University Hospital Center of Martinique	N/A
Completed	A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inact NCT02963909	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Completed	ZIKA Vaccine in Naive Subjects NCT02952833	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Completed	Sensorimotor Outcomes of Children Exposed to Foetal Zika Virus Infection NCT03679728	University of Sao Paulo	—
Unknown	Vertical Exposure to Zika Virus and Its Consequences for Child Neurodevelopment (ZIKVIRUSIFF) NCT03255369	Oswaldo Cruz Foundation	—
Completed	Neurologic Manifestations of the Arbovirus Infection in Colombia NCT03206541	Johns Hopkins University	—